Toshiba America Medical Systems, Inc.

In the last five years, the Affordable Care Act (ACA) has transformed the way healthcare providers conduct business and deliver patient care. Quality measures are directly linked to patient safety and satisfaction, and providers are reimbursed based on their ability to meet these quality measures under reform.

Toshiba America Medical Systems, Inc. understands healthcare providers’ business and develops innovative solutions to improve patient safety for a variety of imaging needs, such as the Dose Tracking System (DTS) for its cardiovascular X-ray systems and Superb Micro-Vascular Imaging (SMI) for ultrasound. By incorporating imaging technologies that are aimed at patient safety, healthcare providers can improve the overall patient experience and satisfaction to achieve reforms’ quality measures.

Making real-time dose management for cardiovascular X-ray possible
Reducing dose is a very important part of any provider’s approach to improving patient safety. Toshiba’s Infinix™ cardiovascular X-ray systems feature a comprehensive selection of tableside dose management tools to assist physicians with managing dose and delivering high quality images. Toshiba’s latest dose management technology, Dose Tracking System (DTS), measures estimated peak radiation skin dose in real time during interventional procedures, allowing for safer exams and a better patient experience. DTS also offers expanded bi-plane (frontal and lateral) coverage and the ability to track cradle movement, allowing the technology to monitor dose in a wider range of applications, such as neurovascular procedures.

Improving blood flow visualization without contrast agents
Toshiba offers clinicians a faster and safer way to image low blood flow states with Superb Micro-Vascular Imaging (SMI) for its AplioTM 500 Platinum ultrasound system. SMI makes it possible for clinicians to use ultrasound to see small vessels in and around areas, such as tumors and lymph nodes, and visualize low-velocity microvascular blood flow without the need for contrast agents or invasive modalities. Expanding the utility of ultrasound, SMI contributes to fewer ionizing procedures for safer patient care.

About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit Toshiba’s website at www.medical.toshiba.com.

Editor’s note: Sponsored by Toshiba America Medical Systems, Inc.